CHAMPIONS ONCOLOGY, INC. Payments of Financing Costs
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Payments of Financing Costs of $742.00 thousand for the 12-month period ending 2017-04-30, per its 10-K filed 2018-07-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2018-07-30
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for the quarter ending 2017-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for the quarter ending 2017-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for the quarter ending 2016-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for the quarter ending 2016-07-31 was $742.00K.
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for fiscal 2017 was $742.00K.
- CHAMPIONS ONCOLOGY, INC. payments of financing costs for fiscal 2015 was $880.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2017-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $0.00 derived: sum of 2 quarters · filed 2018-07-30 | $0.00 derived: sum of 3 quarters · filed 2018-07-30 | $742.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $0.00 derived: sum of 2 quarters · filed 2018-03-19 | $742.00K 10-Q · filed 2018-03-19 | |
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $742.00K 10-Q · filed 2017-12-15 | ||
| 2016-07-31 | $742.00K 10-Q · filed 2017-09-14 | |||
| 2015-04-30 | $880.00K 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |